Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal barrier restoration does not refer to a specific molecule or receptor. Instead, it describes the process of repairing or enhancing the physical and chemical barriers formed primarily by the stratum corneum—the outermost layer of the epidermis. This complex structure consists mainly of corneocytes embedded in lipid matrices composed of ceramides, fatty acids, and cholesterol. Key proteins such as filaggrin aggregate keratin fibers within cells and are degraded into natural moisturizing factors that help retain moisture. The acid mantle (skin pH) also plays an important role in maintaining enzymatic activity for lipid processing and antimicrobial defense. Disruption of this multi-component system leads to increased water loss from the skin surface (transepidermal water loss), greater vulnerability to allergens/infections, and contributes significantly to diseases like atopic dermatitis. Because "epidermal barrier restoration" refers broadly to improving this multifactorial system rather than modulating one defined protein/receptor/enzyme/transporter/etc., it should not be considered a canonical therapeutic target. In summary: "Epidermal barrier restoration" is not itself a molecular entity but rather an important physiological process involving multiple structural proteins (e.g., filaggrin), lipids (ceramides/fatty acids/cholesterol), enzymes involved in their synthesis/breakdown, acidic pH maintenance mechanisms, immune components, etc.
Drugs that "restore" the epidermal barrier generally work by supplementing lipids/ceramides or reducing inflammation rather than targeting a specific molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal barrier restoration.